TY - JOUR
T1 - Access to opioid analgesics and pain relief for patients with cancer
AU - Dalal, Shalini
AU - Bruera, Eduardo
N1 - Funding Information:
E. Bruera is supported in part by National Institutes of Health grant numbers: RO1NR010162-01A1, RO1CA122292-01, and RO1CA124481-01.
PY - 2013/2
Y1 - 2013/2
N2 - Access to pain relief is a crucial concern for patients with cancer, and remains so at all stages of the illness trajectory. This Review covers the scope of the problem and considers the optimal palliative strategy, mainly through the use of opioids. It also discusses various barriers to effective pain management around the world, including regulatory and attitudinal barriers towards opioids, and the unwillingness of national governments to integrate palliative care effectively in cancer control efforts.
AB - Access to pain relief is a crucial concern for patients with cancer, and remains so at all stages of the illness trajectory. This Review covers the scope of the problem and considers the optimal palliative strategy, mainly through the use of opioids. It also discusses various barriers to effective pain management around the world, including regulatory and attitudinal barriers towards opioids, and the unwillingness of national governments to integrate palliative care effectively in cancer control efforts.
UR - http://www.scopus.com/inward/record.url?scp=84873407786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873407786&partnerID=8YFLogxK
U2 - 10.1038/nrclinonc.2012.237
DO - 10.1038/nrclinonc.2012.237
M3 - Review article
C2 - 23319138
AN - SCOPUS:84873407786
SN - 1759-4774
VL - 10
SP - 108
EP - 116
JO - Nature Reviews Clinical Oncology
JF - Nature Reviews Clinical Oncology
IS - 2
ER -